Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07452432) titled 'Korean Prospective Upper Tract Urothelial Carcinoma Cohort' on Feb. 28.

Study Type: Observational [Patient Registry]

Primary Sponsor: Samsung Medical Center

Condition: Urothelial Carcinoma (UC)

Intervention: Other: Peripheral blood collection for ctDNA analysis

Recruitment Status: Recruiting

Date of First Enrollment: January 1, 2026

Target Sample Size: 300

Countries of Recruitment: South Korea

To know more, visit https://clinicaltrials.gov/study/NCT07452432

Published by HT Digital Content Services with permission from Health Daily Digest....